{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:19:52Z","timestamp":1790763592665,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"vor","delay-in-days":568,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["T32HD075735"],"award-info":[{"award-number":["T32HD075735"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002581","name":"School of Medicine, CHA University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150300-01S1"],"award-info":[{"award-number":["R01AI150300-01S1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI148963"],"award-info":[{"award-number":["R01AI148963"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI151029"],"award-info":[{"award-number":["R01AI151029"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.immuni.2022.09.007","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T12:42:18Z","timestamp":1665751338000},"page":"2074-2084.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome"],"prefix":"10.1016","volume":"55","author":[{"given":"Louise","family":"Malle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Martin-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofija","family":"Buta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-3232","authenticated-orcid":false,"given":"Dusan","family":"Bogunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2022.09.007_bib1","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1056\/NEJMoa1905633","article-title":"JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency","volume":"382","author":"Alsohime","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib2","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20142274","article-title":"Functional IRF3 deficiency in a patient with herpes simplex encephalitis","volume":"212","author":"Andersen","year":"2015","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib3","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/652420","article-title":"Safely, tolerability, and mechanisms of antiretroviral activity of pegylated interferon alfa-2a in HIV-1monoinfected participants: A phase II clinical trial","volume":"201","author":"Asmuth","year":"2010","journal-title":"JID (J. Infect. Dis.)"},{"key":"10.1016\/j.immuni.2022.09.007_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1001\/jama.2018.2089","article-title":"Trends and Patterns of Differences in Infectious Disease Mortality Among US Counties, 1980-2014","volume":"319","author":"Bcheraoui","year":"2018","journal-title":"JAMA. American Medical Association"},{"key":"10.1016\/j.immuni.2022.09.007_bib5","doi-asserted-by":"crossref","first-page":"17928","DOI":"10.1074\/jbc.M117.788877","article-title":"SOCS1 is an inducible negative regulator of interferon \u03bb (IFN-\u03bb)\u2013induced gene expression in\u00a0vivo","volume":"292","author":"Blumer","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2022.09.007_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.coi.2012.04.011","article-title":"Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes","volume":"24","author":"Boisson-Dupuis","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib7","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00134-007-0803-z","article-title":"High incidence of acute lung injury in children with Down syndrome","volume":"33","author":"Bruijn","year":"2007","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib8","doi-asserted-by":"crossref","unstructured":"Bull, M. J. (2020) \u2018Down syndrome\u2019, N. Engl. J. Med. Edited by A. H. Ropper. Massachusetts Medical Society, 382, pp. 2344\u20132352. https:\/\/doi.org\/10.1056\/NEJMra1706537.","DOI":"10.1056\/NEJMra1706537"},{"key":"10.1016\/j.immuni.2022.09.007_bib9","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1128\/JVI.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome\u2019, Journal of virology","volume":"81","author":"Cameron","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2022.09.007_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2022.09.007_bib11","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes\u2019","volume":"129","author":"Channappanavar","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2022.09.007_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.aaa1578","article-title":"Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency","volume":"348","author":"Ciancanelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.09.007_bib13","first-page":"M20","article-title":"COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults","author":"Clift","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib14","article-title":"Pulmonary Complications in Children with Down Syndrome: A Scoping Review","author":"De Lausnay","year":"2021","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.immuni.2022.09.007_bib15","doi-asserted-by":"crossref","first-page":"307ra154","DOI":"10.1126\/scitranslmed.aac4227","article-title":"Human IFNAR2 deficiency: Lessons for antiviral immunity\u2019, Science translational medicine","volume":"7","author":"Duncan","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib16","first-page":"64","article-title":"Prevalence of Infectious Diseases Among 6078 Individuals With Prevalence of Infectious Diseases Among 6078 Individuals With Down Syndrome in the United States","volume":"9","author":"Fitzpatrick","year":"2022","journal-title":"J.\u00a0Patient. Cent. Res. Rev."},{"key":"10.1016\/j.immuni.2022.09.007_bib17","series-title":"\u2018USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon \u03b1 Response\u2019, PLoS ONE","volume":"6","author":"Fran\u00e7ois-Newton","year":"2011"},{"key":"10.1016\/j.immuni.2022.09.007_bib18","article-title":"A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients","author":"Geanon","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.immuni.2022.09.007_bib19","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.1220098110","article-title":"STAT2 deficiency and susceptibility to viral illness in humans","volume":"110","author":"Hambleton","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.immuni.2022.09.007_bib20","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.20182295","article-title":"Inherited IFNAR1 deficiency in otherwise healthy patients with adverse reaction to measles and yellow fever live vaccines","volume":"216","author":"Hernandez","year":"2019","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S2213-2600(21)00384-2","article-title":"Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Kalil","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib22","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","article-title":"Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome","volume":"40","author":"Kong","year":"2020","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev-med-050715-104506","article-title":"The Type I Interferonopathies","author":"Lee-Kirsch","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib24","first-page":"1420","article-title":"National population-based estimates for major birth defects, 2010\u20132014","volume":"111","author":"Mai","year":"2019"},{"key":"10.1016\/j.immuni.2022.09.007_bib25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41436-020-01004-w","article-title":"Individuals with Down syndrome hospitalized with COVID-19 have more severe disease","volume":"23","author":"Malle","year":"2020","journal-title":"Genet. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib26","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10875-021-01078-4","article-title":"Atypical Inflammatory Syndrome Triggered by SARS-CoV-2 in Infants with Down Syndrome","volume":"41","author":"Malle","year":"2021","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib46","doi-asserted-by":"crossref","first-page":"e2005970","DOI":"10.1371\/journal.pbio.2005970","article-title":"CellProfiler 3.0: Next-generation image processing for biology","volume":"16","author":"McQuin","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.immuni.2022.09.007_bib27","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20151529","article-title":"Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome","volume":"213","author":"Meuwissen","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpeds.2018.08.006","article-title":"Hospitalization for Respiratory Syncytial Virus in Children with Down Syndrome Less than 2 Years of Age: A Systematic Review and Meta-Analysis","volume":"203","author":"Mitra","year":"2018","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.immuni.2022.09.007_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-2600(20)30511-7","article-title":"Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Monk","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib30","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jar.12446","article-title":"Early death and causes of death of people with Down syndrome: A systematic review","volume":"31","author":"O\u2019Leary","year":"2018","journal-title":"J.\u00a0Appl. Res. Intellect. Disabil."},{"key":"10.1016\/j.immuni.2022.09.007_bib31","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.chom.2020.05.008","article-title":"Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19","volume":"27","author":"Park","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.immuni.2022.09.007_bib32","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3201\/eid1608.091931","article-title":"Pandemic (H1N1) 2009 Virus and Down syndrome patients","volume":"16","author":"P\u00e9rez-Padilla","year":"2010","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.immuni.2022.09.007_bib33","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1093\/rheumatology\/keab203","article-title":"JAK inhibition for treatment of psoriatic arthritis in Down syndrome","volume":"60","author":"Pham","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.immuni.2022.09.007_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.it.2015.02.002","article-title":"Dynamic control of type I IFN signalling by an integrated network of negative regulators","volume":"36","author":"Porritt","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","article-title":"CASE REPORT Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata","volume":"5","author":"Rachubinski","year":"2019","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.immuni.2022.09.007_bib36","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1084\/jem.20161596","article-title":"Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview","volume":"213","author":"Rodero","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2022.09.007_bib37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ajmg.a.61924","article-title":"Pneumonia and respiratory infections in Down syndrome: A scoping review of the literature","volume":"185","author":"Santoro","year":"2021","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.immuni.2022.09.007_bib38","doi-asserted-by":"crossref","first-page":"e16220","DOI":"10.7554\/eLife.16220","article-title":"Trisomy 21 consistently activates the interferon response","volume":"5","author":"Sullivan","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.immuni.2022.09.007_bib39","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.4049\/jimmunol.1800764","article-title":"The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics","volume":"201","author":"Taft","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib40","first-page":"31","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016"},{"key":"10.1016\/j.immuni.2022.09.007_bib41","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/jir.12196","article-title":"Risk factors for mortality in Down syndrome","volume":"59","author":"Uppal","year":"2015","journal-title":"J.\u00a0Intellect. Disabil. Res."},{"key":"10.1016\/j.immuni.2022.09.007_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10875-020-00805-7","article-title":"Inborn Errors of Adaptive Immunity in Down Syndrome","author":"Verstegen","year":"2020","journal-title":"J.\u00a0Clin. Immunol."},{"key":"10.1016\/j.immuni.2022.09.007_bib43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2023184","article-title":"Repurposed Antiviral Drugs for Covid-19 \u2014 Interim WHO Solidarity Trial Results","volume":"384","year":"2021","journal-title":"N.\u00a0Engl. J. Med. Overseas. Ed."},{"key":"10.1016\/j.immuni.2022.09.007_bib44","doi-asserted-by":"crossref","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2022.09.007_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature13801","article-title":"Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation","volume":"517","author":"Zhang","year":"2015","journal-title":"Nature"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322005015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761322005015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:59:30Z","timestamp":1777607970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761322005015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1074761322005015"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2022.09.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742367519.793596343","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Excessive negative regulation of type I interferon disrupts viral control in individuals with Down syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2022.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}